HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer

American Journal of Translational Research

Volumn 7, Issue 10, 2015, Pages 2036-2044

  Zhou, Li ^a   Niu, Zhe Yu ^a   Liang, Zhi Yong ^a   Zhou, Wei Xun ^a   You, Lei ^a   Wang, Meng Yi ^a   Yao, Lu Tian ^a   Liao, Quan ^a   Zhao, Yu Pei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Host immune response; Human leucocyte antigen G; Pancreatic cancer; Prognosis

Indexed keywords

CD3 ANTIGEN; HLA G ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING;

EID: 84947744232     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
2. Weber A, Kehl V, Mittermeyer T, Herberich E, Röthling N, Schmid RM and Prinz C. Prognostic factors for survival in patients with unresectable pancreatic cancer. Pancreas 2012; 39: 1247-1253.
3. Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM and White SA. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2012; 38: 333-339.
4. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB and Wang H. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 2012; 36: 409-417.
5. Hallemeier CL, Botros M, Corsini MM, Haddock MG, Gunderson LL and Miller RC. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. Am J Clin Oncol 2011; 34: 567-572.
6. Ansari D, Rosendahl A, Elebro J and Andersson R. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg 2011; 98: 1041-1055.
7. Winter JM, Yeo CJ and Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 2013; 107: 15-22.
8. Geraghty DE, Koller BH and Orr HT. A human major histocompatibility complex class I gene that encodes a protein with shortened cytoplasmic segment. Proc Natl Acad Sci U S A 1987; 84: 9145-9149.
9. Curigliano G, Criscitiello C, Gelao L and Goldhirsch A. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res 2013; 19: 5564-5571.
10. Lopez-Botet M, Navarro F and Llano M. How do NK cells sense the expression of HLA-G class Ib molecules? Semin Cancer Biol 1999; 9: 19-26.
11. Gao GF, Willcox BE, Wyer JR, Boulter JM, O’Callaghan CA, Maenaka K, Stuart DI, Jones EY, Van Der Merwe PA, Bell JI and Jakobsen BK. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 alpha-alpha. J Biol Chem 2000; 275: 15232-15238.
12. Fons P, Chabot S, Cartwright JE, Lenfant F, LFaqihi F, Giustiniani J, Herault JP, Gueguen G, Bono F, Savi P, Aguerre-Girr M, Fournel S, Malecaze F, Bensussan A, Plouët J and Le Bouteiller P. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006; 108: 2608-2615.
13. Ye SR, Yang H, Li K, Dong DD, Lin XM and Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007; 20: 375-383.
14. Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007; 14: 2721-2729.
15. Du L, Xiao X, Wang C, Zhang X, Zheng N, Wang L, Zhang X, Li W, Wang S and Dong Z. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Sci 2011; 102: 1272-1280.
16. Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in nonsmall cell lung cancer. Lung Cancer 2007; 58: 267-274.
17. Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 2007; 128: 1002-1009.
18. Lin A, Zhang X, Zhou WJ, Ruan YY, Xu DP, Wang Q and Yan WH. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Cancer 2011; 129: 1382-1390.
19. Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J and Fan J. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009; 15: 4686-4693.
20. Wang Y, Ye Z, Meng XQ and Zheng SS. Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011; 10: 158-163.
21. Jung YW, Kim YT, Kim SW, Kim S, Kim JH, Cho NH and Kim JW. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Reprod Sci 2009; 16: 1103-1111.
22. Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ, Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, Chen LZ, Kang TB, Shao JY and Zeng YX. Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. Int J Biol Sci 2012; 8: 891-900.
23. Dong DD, Yie SM, Li K, Li F, Xu Y, Xu G, Song L and Yang H. Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer. Hum Immunol 2012; 73: 998-1004.
24. Nunes LM, Ayres FM, Francescantonio IC, Saddi VA, Avelino MA, Alencar Rde C, Silva RC, Meneghini AJ and Wastowski IJ. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer. Hum Immunol 2013; 74: 447-451.
25. Zeestraten EC, Reimers MS, Saadatmand S, Dekker JW, Liefers GJ, van den Elsen PJ, van de Velde CJ and Kuppen PJ. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer 2014; 110: 459-468.
26. Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJ and Kuppen PJ. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer 2014; 14: 486.
27. Rutten MJ, Dijk F, Savci-Heijink CD, Buist MR, Kenter GG, van de Vijver MJ and Jordanova ES. HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas. J Immunol Res 2014; 2014: 274584.
28. Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ and Maitra A. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer 2005; 35: 15-23.
29. Tewari N, Zaitoun AM, Arora A, Madhusudan S, Ilyas M and Lobo DN. The presence of tumourassociated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays. BMC Cancer 2013; 13: 436.
30. Appel BL, Tolat P, Evans DB and Tsai S. Current staging systems for pancreatic cancer. Cancer J 2012; 18: 539-549.
31. Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P and Pelley RJ. A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators. J Gastrointest Surg 2010; 14: 1159-1169.
32. Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, Büchler MW and Werner J. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 2011; 254: 311-319.
33. Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T and Nagayasu T. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Hepatogastroenterology 2012; 59: 911-915.
34. AlGhamdi HJ, Alfaifi SA, Alolayan AA, Musaad SM and Jazieh AM. Pancreatic cancer in Saudi patients treated at tertiary institution. Ten years retrospective study. Saudi Med J 2013; 34: 604-608.
35. Clevers H, Alarcon B, Wileman T and Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988; 6: 629-662.